First OC Dermatology Research, Inc. | Fountain Valley, CA

Research site
17271 Brookhurst Street, Fountain Valley, California, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


3 of 3
Status: Active
Trial type: Interventional
Funder type: Industry

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis (REZOLVE-AD)

This is an interventional, randomized, parallel group, treatment, Phase IIb, double blind, 4-arm study to assess the effect of pegylated-recombinant-...

Moderate to Severe Atopic Dermatitis
Drug: Placebo
Drug: Rezpegaldesleukin

This is a randomized, double-blind, placebo-controlled, single- and multiple ascending dose study of subcutaneous (SC) administration of NM26-2198 in...

Atopic Dermatitis
Other: Placebo
Biological: NM26-2198

The purpose of this study is to determine the efficacy and safety of a monoclonal antibody, OpSCF, in the treatment of adults with moderate to severe...

Atopic Dermatitis
Biological: OpSCF
Biological: Placebo

Trial conditions

Atopic Dermatitis (3 trials)
Dermatitis (3 trials)
Eczema (3 trials)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems